1. U.S. National Cancer Institute’s Common Toxicity Criteria and the Common Terminology Criteria for Adverse Events for classifying and grading severity of adverse events caused by investigational therapy during clinical trials, available at http://evs.nci.nih.gov/ftp1/CTCAE/About.html .
2. Williams WJ. Examination of the blood. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, editors. Hematology. 3rd ed. New York, NY: McGraw-Hill; 1983. p. 9–24.
3. Lichtman MA. Clinical manifestations of granulocyte and monocyte disorders. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, editors. Hematology. 3rd ed. New York, NY: McGraw-Hill; 1983. p. 63–6.
4. Smith JE. Comparative hematology. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, editors. Hematology. 3rd ed. New York, NY: McGraw-Hill; 1983. p. 117–25.
5. Williams WJ. Clinical manifestations of disorders of hemostasis. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, editors. Hematology. 3rd ed. New York, NY: McGraw-Hill; 1983.p. 69–72.